Advaxis, Inc., a development stage biotechnology company, engages in the research and development of new cancer-fighting techniques. It develops cancer vaccines targeting cervical, breast, prostate, ovarian, lung, and other cancers. The company’s products in development include Lovaxin C, a Phase I/II trial product to treat cervical intraepithelial neoplasia, cervical cancer, and head and neck cancer; Lovaxin P, a preclinical stage product for prostate cancer; and Lovaxin B, a preclinical stage product to treat breast cancer. Advaxis has strategic collaboration with Cobra Biomanufacturing PLC for manufacturing cervical cancer vaccine.
ADXS at 10:10 AM 1/6/2009: Up 175% For The Day.
Tags: OTC Bulletin Board, OTCBB, OTCBB Stocks
Leave a Reply
You must be logged in to post a comment.
